Evidence map›Paper›PMID 33117376›Full record

ArticleFrontiers in immunology2020

Jiang Bian, Ke Wang, Qilan Wang, Pu Wang, Ting Wang, Weiyun Shi, Qingguo Ruan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Overexpression ofaBIOTECH · 2026
    Article
  2. A Comprehensive Review of the Phenolic Compounds inMolecules (Basel, Switzerland) · 2025
    Review
  3. Review
  4. The Isolation and Preparation of Samwinol fromInternational journal of molecular sciences · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jiang BianQingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
Ke WangDepartment of Ophthalmology, Qingdao University Medical College, Qingdao, China.
Qilan WangNorthwest Plateau Institutes of Biology, Chinese Academy of Sciences, Xining, China.
Pu WangCenter for Antibody Drug, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Ting WangState Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao, China.
Weiyun ShiState Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao, China.
Qingguo RuanState Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Qingdao, China.
Shandong First Medical University · CNChinese Academy of Sciences · CNQingdao University · CNShandong Eye Hospital · CNXinjiang Institute of Ecology and Geography · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Experimental autoimmune uveitis (EAU) is a CD4

Indexed as

AnimalsAnti-Inflammatory AgentsAutoimmune DiseasesAutoimmunityCD4-Positive T-LymphocytesCDC2 Protein KinaseCell ProliferationCells, CulturedCytokinesDisease Models, AnimalDrugs, Chinese HerbalFemaleG2 Phase Cell Cycle CheckpointsInflammation MediatorsLamiaceaeMice, Inbred C57BLAnti-Inflammatory AgentsCDC2 Protein KinaseCdk1 protein, mouseCytokinesDrugs, Chinese HerbalInflammation MediatorsPlant Extractsautoimmunityexperimental autoimmune uveitisherbal medicineproliferationT cell

Identifiers

PMID33117376
PMCPMC7578250
OpenAlexW3092184680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.